Our Global Health Economics and Outcomes Research (GHEOR) group specializes in the development and execution of studies that focus on assessing the direct costs of medical expenditures; indirect costs associated with work loss and disability; the impact of treatments, diseases, and conditions on patients’ health and well-being. Our strategic approach and experience in patient-reported outcomes enables us to gather information about the ways a treatment or intervention affects medical resource use, to evaluate a therapy’s effectiveness, and to support more comprehensive clinical decision-making. To compliment these results, our health economics component establishes product value for our clients through the provision of economic strategy and planning, prospective research, economic modeling, retrospective database analysis and dossier development.